Refreshing results…
Lorlatinib for advanced ROS1+ non-small-cell lung cancer: results of the IFCT-1803 LORLATU study
UploadEfficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma
UploadOptimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients
UploadMissing publications? Search for publications with a matching author name.